Carl Dambkowski, Director: Oruka Therapeutics ORKA Sell · Filed 06/12

Trade details

Type: Insider sale
Amount: $882,194.13
Shares · price: 12,583 sh · $70.11 a share
Held after: 38,743 sh
Stock: Oruka Therapeutics ORKA
Person: Carl DambkowskiDirector
Trade date: 26/06/12
Filed: 26/06/12
Days to filing: 0 days

Sold 24.5% of holdings

Share of holding sold: 24.5%

Oruka Therapeutics trades, last 26 weeks

What else happened in Oruka Therapeutics around then

Filed or reported within 30 days of the trade day · 05/13~07/12

Carl Dambkowski's recent trades

Carl DambkowskiChief Medical Officer
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$3.5M
26,400 sh
$3.5M
Filed 06/24
Traded 06/22
Carl DambkowskiDirector
Sell10b5-1 planOruka Therapeutics
Sell10b5-1 plan
Oruka Therapeutics
ORKA
$1.6M
22,417 sh
$1.6M
Filed 06/12
Traded 06/11
Carl DambkowskiDirector
Planned sale10b5-1 planOruka Therapeutics
Planned sale10b5-1 plan
Oruka Therapeutics
ORKA
$2.2M
35,000 sh
$2.2M
Filed 06/11
Traded 06/11
Carl DambkowskiChief Medical Officer
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$432.9K
5,500 sh
$432.9K
Filed 06/05
Traded 06/03
Carl DambkowskiDirector
Sell10b5-1 planOruka Therapeutics
Sell10b5-1 plan
Oruka Therapeutics
ORKA
$3.2M
53,447 sh
$3.2M
Filed 05/22
Traded 05/21